Note 13 - Segment Information

12 Months Ended

Jun. 30, 2022

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note 13. Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into two reportable segments; Contract Manufacturing and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe, for the fiscal years ended June 30, 2022 and 2021 were $9,729 and $9,172, respectively.

Financial information relating to the fiscal years ended June 30, 2022 and 2021 operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital		Total
		Customers		Customers		Total		Profit		Depreciation		Expenditures		Assets
Contract Manufacturing	2022	$	44,450	$	9,641	$	54,091	$	5,917	$	332	$	486	$	19,061
	2021		52,763		9,072		61,835		9,020		332		292		21,333
Other Nutraceutical Businesses	2022		2,067		88		2,155		635		4		-		6,189
	2021		1,624		100		1,724		460		5		3		4,107
Total Company	2022		46,517		9,729		56,246		6,552		336		486		25,250
	2021		54,387		9,172		63,559		9,480		337		295		25,440